drugset / Trial / NCT01708057

A Single-dose Study to Investigate the Effects of 4 Different Doses of Inhaled AZD8683 in Chronic Obstructive Pulmonary Disease (COPD) Patients

NCT01708057

Phase 2 Terminated 3 enrolled AstraZeneca
RandomizedCrossoverDouble-blindTreatment

Summary

This study in Chronic Obstructive Pulmonary Disease (COPD) patients will investigate the bronchodilatory effect of AZD8683. AZD8683 will be tested versus placebo and an active comparator.

Timeline

Start
2012-10
Primary completion
2012-12
Completion
2012-12

Drugs

EvaluationDrugModalityDoseRoute
Subject AZD8683 Unknown 50 ug Inhaled
Subject AZD8683 Unknown 150 ug Inhaled
Subject AZD8683 Unknown 300 ug Inhaled
Subject AZD8683 Unknown 900 ug Inhaled
Comparator Tiotropium Other / unclassified 18 ug Inhaled